Neurable Inc. just closed a $35M Series A and this one does not read like a hype cycle. It reads like a balance sheet finally catching up to a decade of serious neuroscience. Founded in March 2015 out of the University of Michigan Direct Brain Interface Laboratory, Neurable spent 10+ years doing the work most people skip. Signal fidelity. Validation. Patents. The kind of progress that compounds quietly until it stops being quiet.
Dr. Ramses Alcaide is not a storyteller pretending to be a scientist. He is a neuroscientist who decided the lab was not the finish line. PhD in Electrical Engineering and Neuroscience, years inside the Direct Brain Interface Lab, and research grounded in real human data, more than 8,000 users worth. Adam Molnar complements that with the other half of the equation, global commercialization, policy, and ethics, making sure deep tech does not stall at the whiteboard.
Spectrum Moonshot Fund led the round with Mauro Guebeli backing it, Pace Ventures stayed in with Marius Swart, and the message is discipline. Total capital now sits at $65M. No valuation headline. No chest beating. That restraint usually shows up when everyone at the table already knows what the platform is worth and where it is headed.
Neurable builds noninvasive brain computer interface tech that fits into real life. The MW75 Neuro and MW75 Neuro LT look like premium headphones because they are. Inside is a 12 channel EEG system with lab grade accuracy, soft fabric sensors, and AI-trained across a decade of signal processing. Brain data becomes as easy to check as sleep or heartrate, except now it captures focus, fatigue, recovery, and cognitive drift in real time.
This is not a demo loop. Mayo Clinic validated it. The U.S. Air Force Research Lab tested it. The U.S. Department of Defense awarded $5M in contracts. iMotions integrated it for researchers. Healthspan Digital is taking it global starting in Dubai. Gaming, workplace performance, cognitive health, and longevity all converge when the brain becomes measurable outside a lab.
45+ patents protect the stack. 9 peer reviewed papers explain it. Consumer products prove it. This round scales it. The BCI market is projected to grow from $2.94B in 2025 to $12.4B by 2034, with noninvasive tech holding over 80% of revenue share. Neurable built exactly where the demand is moving.
The real takeaway is uncomfortable for anyone chasing shortcuts. Breakthroughs rarely arrive loud. They arrive precise. Neurable earned trust signal by signal, partnership by partnership, year by year. Now the market is catching up to the work, and the work is not slowing down.
Startups Startup Funding Venture Capital Series A AI BCI NeuroTech Healthcare HealthTech Wearables DeepTech Data Data Driven Technology Innovation Tech Ecosystem Startup Ecosystem DCTalks
